ToxStrategies is pleased to announce that Dr. Kristina Ulrich has joined our Biopharmaceuticals and Pharmaceuticals practice. Dr. Ulrich is a European Registered Toxicologist (ERT) and a former nonclinical assessor at the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. She brings 15 years of experience in pharmaceutical development, along with her background and expertise in the European regulatory arena. In the pharmaceutical industry, she has led the nonclinical safety strategy for products in development and has provided toxicology input for pharmaceutical in-licensing opportunities. Dr. Ulrich holds a Ph.D. in Biomedical Science from Imperial College in London and an M.Sc. in Applied Toxicology from the University of Surrey. She will practice from a satellite office near Cambridge.
ToxStrategies consulting scientists provide a range of services in nonclinical toxicology, offering a broad knowledge base in the regulatory environments of multiple jurisdictions. Please click here for additional information on our Biopharmaceuticals/Pharmaceuticals practice.